3i investment fund, which took over around 49% in stock of Centrul Medical Unirea (CMU) clinic operator in 2007, is likely to sell its stake, having started procedures in this regard. This is the third clinic network put up for sale this year, after MedLife and Romar. “3i is contemplating the possibility of selling its stake,” said Sergiu Negut, CMU CEO. He added this was an internal decision of the investment fund. 3i’s stakes in Romania are managed by 3TS Capital Partners. CMU for this year has budgeted turnover worth 16m euros and 4.6m-euro EBITDA. According to industry people surveyed by ZF, at this level of turnover the company could be valued at 46m euros, so that a deal with almost 50% in stock may amount to over 20m euros. While talks for the sale of CMU are in their early stages, the sale of MedLife is about to be concluded. Cumulated deals in this industry may go beyond 40m euros by yearend.
ZF English
3i investment fund, readying to exit Centrul Medical Unirea
3i investment fund, which took over around 49% in stock of Centrul Medical Unirea (CMU) clinic operator in 2007, is likely to sell its stake, having started procedures in this regard. This is the third clinic network put up for sale this year, after MedLife and Romar.